Vito Lorusso

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

David Cunningham, István Láng, Eugenio Marcuello et al. · The Lancet Oncology · 2013 · 642 citations

Elderly Patients, Gastrointestinal Oncology, Medicine +10

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Matti Aapro, H. S. Rugo, Giada Rizzi et al. · Annals of Oncology · 2014 · 244 citations · Full text

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

Alberto Spinazzi, Vito Lorusso, Gianpaolo Pirovano et al. · Academic Radiology · 1999 · 202 citations

Gadobenate Dimeglumine, Hepatology, Medical Imaging +13

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

M. De Lena, Vito Lorusso, Agnese Latorre et al. · European Journal of Cancer · 2001 · 167 citations

Advanced Ovarian Cancer, Medicine, Pharmacology +8

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Fortunato Ciardiello, Nicola Normanno, Erika Martinelli et al. · Annals of Oncology · 2016 · 97 citations

Gastrointestinal Oncology, Cetuximab Continuation, Medicine +8